Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCD-131 vs Mircera in Anemia of CKD on Dialysis
NCT03519243Phase 2Completed
- Sponsor
- BIOCAD
- Start
- Oct 2017
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes, PEGylated Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of pegylated darbepoetin beta in anemia of chronic kidney disease (CKD-A), sponsored by BIOCAD. Started Oct 2017; status: completed.
02
Drugs
pegylated darbepoetin beta
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT03519243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03519243.